Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Raysearch Laboratories

190.60 SEK

-0.42 %

Less than 1K followers

RAY B

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Raysearch Laboratories

Q3/24Q4/242024Q1/25Q2/25Q3/25Q4/252025
Revenue293.3322.71,192.0331.7304.9332.3375.41,344.3
EBITDA134.8151.8558.0145.1108.9162.3167.3583.6
EBIT61.873.6260.574.836.489.291.9292.3
EBIT-%21.1 %22.8 %21.9 %22.6 %11.9 %26.8 %24.5 %21.7 %
Profit before taxes58.377.4262.971.039.688.588.7287.8
Net income45.460.0203.556.830.871.668.6227.8
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.